News about Biotechnology

Lilly Bets Big on Precision Immunology in USD 1.93 Billion Partnership

Eli Lilly and Company has entered into a strategic collaboration with biotechnology firm Repertoire Immune Medicines in a deal valued at up to USD 1.93 billion to develop novel therapies for autoimmune diseases.

Biotechnology | 30/01/2026 | By Darshana |  168

FDA Grants Breakthrough Therapy Designation to Biogen's Litifilimab for Cutaneous Lupus

Biogen’s investigational monoclonal antibody litifilimab receives FDA Breakthrough Therapy designation, marking a major step toward targeted treatment for cutaneous lupus erythematosus.

Biotechnology | 29/01/2026 | By News Bureau |  189

GSK to Acquire RAPT Therapeutics for USD 2.2 Billion to Strengthen Food Allergy and Immunology Pipeline

GSK will acquire RAPT Therapeutics for USD 2.2 billion, adding phase IIb anti-IgE antibody ozureprubart to its pipeline, targeting long-acting protection for patients with severe food allergies.

Biotechnology | 20/01/2026 | By News Bureau |  215

Onyx Scientific Strengthens Solid Form Screening Platform Following 25-Year Milestone

Onyx Scientific, the contract development and manufacturing organisation (CDMO) division of Ipca Laboratories, has announced plans to expand its solid form and material science screening capabilities in 2026, following the celebration of its 25th anniversary at the end of 2025.

Biotechnology | 20/01/2026 | By Darshana |  242

European Commission Approves Sobi's Aspaveli for Rare Kidney Diseases C3G and IC-MPGN

The European Commission has approved Sobi’s Aspaveli for adolescents and adults with rare kidney diseases C3G and IC-MPGN, marking the first approved therapy for these conditions.

Biotechnology | 19/01/2026 | By News Bureau |  215

IDT- Ansa Alliance Brings High-Complexity, Long-Length DNA Synthesis to Global Researchers

Integrated DNA Technologies (IDT), a Danaher company and a global genomics solutions provider, has entered into a strategic collaboration with Ansa Biotechnologies Inc to enhance its synthetic biology portfolio with advanced DNA synthesis capabilities.

Biotechnology | 17/01/2026 | By Darshana |  268

BD Secures FDA 510(k) Clearance for EnCor EnCompass Multi-Modality Breast Biopsy System

BD has received FDA 510(k) clearance for its EnCor EnCompass multi-modality breast biopsy system, designed to improve procedural efficiency, clinician flexibility and early detection and diagnosis of breast disease.

Biotechnology | 17/01/2026 | By News Bureau |  177

Risa Labs Raises USD 11.1M Series A to Scale AI OS for Oncology Care

The funding led by Cencora Ventures and Optum Ventures will accelerate nationwide deployment of Risa’s AI-driven platform to streamline oncology workflows, reduce delays and improve patient access to cancer therapies.

Biotechnology | 14/01/2026 | By News Bureau |  332

Dr Jitendra Singh Inaugurates SAMARTH Skill Centre, iDeA-NA Tech Incubator at DBT-CDFD, Hyderabad

While inaugurating the initiatives, Dr Jitendra Singh, Union Minister of State (Independent Charge), Science & Technology, Earth Sciences, and Minister of State, PMO, Department of Space and Department of Atomic Energy, highlighted India’s transition towards futuristic healthcare, early disease detection, affordability and personalised medicine.

Biotechnology | 12/01/2026 | By News Bureau |  177

Biocon Biologics to Showcase Keytruda and Two New Oncology Biosimilars at JPM 2026

Biocon Biologics, the biosimilars arm of Biocon Ltd, is set to introduce three new oncology biosimilars, including a biosimilar of pembrolizumab (Keytruda), at the J.P. Morgan Healthcare Conference 2026 in San Francisco.

Biotechnology | 07/01/2026 | By Darshana |  376